Department of Molecular Physiology and Biophysics, Cardiovascular Research Institute, University of Vermont, Burlington, VT, USA.
Department of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA, USA.
J Gen Physiol. 2024 Jun 3;156(6). doi: 10.1085/jgp.202313522. Epub 2024 May 6.
Dilated cardiomyopathy (DCM) is a condition characterized by impaired cardiac function, due to myocardial hypo-contractility, and is associated with point mutations in β-cardiac myosin, the molecular motor that powers cardiac contraction. Myocardial function can be modulated through sequestration of myosin motors into an auto-inhibited "super-relaxed" state (SRX), which may be further stabilized by a structural state known as the "interacting heads motif" (IHM). Here, we sought to determine whether hypo-contractility of DCM myocardium results from reduced function of individual myosin molecules or from decreased myosin availability to interact with actin due to increased IHM/SRX stabilization. We used an established DCM myosin mutation, E525K, and characterized the biochemical and mechanical activity of wild-type and mutant human β-cardiac myosin constructs that differed in the length of their coiled-coil tail, which dictates their ability to form the IHM/SRX state. We found that short-tailed myosin constructs exhibited low IHM/SRX content, elevated actin-activated ATPase activity, and fast velocities in unloaded motility assays. Conversely, longer-tailed constructs exhibited higher IHM/SRX content and reduced actomyosin ATPase and velocity. Our modeling suggests that reduced velocities may be attributed to IHM/SRX-dependent sequestration of myosin heads. Interestingly, longer-tailed E525K mutants showed no apparent impact on velocity or actomyosin ATPase at low ionic strength but stabilized IHM/SRX state at higher ionic strength. Therefore, the hypo-contractility observed in DCM may be attributable to reduced myosin head availability caused by enhanced IHM/SRX stability in E525K mutants.
扩张型心肌病(DCM)是一种以心肌收缩力减弱为特征的心脏功能障碍疾病,与β-心脏肌球蛋白的点突变有关,后者是驱动心脏收缩的分子马达。心肌功能可以通过肌球蛋白马达进入自动抑制的“超松弛”状态(SRX)来调节,这种状态可以通过一种称为“相互作用头部模体”(IHM)的结构状态进一步稳定。在这里,我们试图确定 DCM 心肌的低收缩性是由于单个肌球蛋白分子的功能降低,还是由于 IHM/SRX 稳定性增加导致肌球蛋白与肌动蛋白相互作用的可用性降低所致。我们使用了一种已建立的 DCM 肌球蛋白突变 E525K,并对野生型和突变型人β-心脏肌球蛋白构建体的生化和机械活性进行了表征,这些构建体在其卷曲螺旋尾巴的长度上有所不同,这决定了它们形成 IHM/SRX 状态的能力。我们发现,短尾肌球蛋白构建体表现出低 IHM/SRX 含量、升高的肌动蛋白激活 ATP 酶活性和未加载运动测定中的快速速度。相反,长尾构建体表现出更高的 IHM/SRX 含量和降低的肌球蛋白-肌动蛋白 ATP 酶和速度。我们的模型表明,降低的速度可能归因于 IHM/SRX 依赖性肌球蛋白头部的隔离。有趣的是,长尾 E525K 突变体在低离子强度下对速度或肌球蛋白-肌动蛋白 ATP 酶没有明显影响,但在较高离子强度下稳定了 IHM/SRX 状态。因此,DCM 中观察到的低收缩性可能归因于 E525K 突变体中 IHM/SRX 稳定性增强导致肌球蛋白头部可用性降低。